Samuele Massarut
Cancer Epidemiology Unit
104 Papers
669 Citations
Samuele Massarut is an academic researcher from Cancer Epidemiology Unit. The author has contributed to research in topics: Breast cancer & Radiation therapy. The author has an hindex of 25, co-authored 90 publications. Previous affiliations of Samuele Massarut include University of Dundee & University of Mannheim.
Chat about Author
Papers
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial
Viviana Galimberti,Bernard F. Cole,Bernard F. Cole,Stefano Zurrida,Giuseppe Viale,Giuseppe Viale,Alberto Luini,Paolo Veronesi,Paolo Veronesi,Paola Baratella,Camelia Chifu,Manuela Sargenti,Mattia Intra,Oreste Gentilini,Mauro G. Mastropasqua,Giovanni Mazzarol,Samuele Massarut,Jean Rémi Garbay,Janez Zgajnar,Hanne Galatius,Angelo Recalcati,David Littlejohn,Monika Bamert,Marco Colleoni,Karen N. Price,Meredith M. Regan,Aron Goldhirsch,Alan S. Coates,Richard D. Gelber,Umberto Veronesi +29 more
TL;DR: Axillary dissection could be avoided in patients with early breast cancer and limited sentinel-node involvement, thus eliminating complications of axillary surgery with no adverse effect on survival.
Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial
Jayant S. Vaidya,Jayant S. Vaidya,Frederik Wenz,Max Bulsara,Jeffrey S Tobias,David Joseph,Mohammed Keshtgar,Henrik Flyger,Samuele Massarut,Michael Alvarado,Christobel Saunders,Christobel Saunders,Wolfgang Eiermann,M Metaxas,Elena Sperk,Marc Sütterlin,Douglas Brown,Laura J. Esserman,Mario Roncadin,Alastair M. Thompson,John Dewar,H Holtveg,Steffi Pigorsch,Mary Falzon,Eleanor E.R. Harris,A Matthews,Chris Brew-Graves,Ingrid Potyka,Tammy Corica,Norman R. Williams,Michael Baum +30 more
TL;DR: 5-year results for local recurrence and the first analysis of overall survival are reported and complications and mortality were much the same between groups but grade 3 or 4 skin complications were significantly reduced with TARGIT.
849
The STROCSS statement: Strengthening the Reporting of Cohort Studies in Surgery
Riaz Agha,Mimi R. Borrelli,Martinique Vella-Baldacchino,Rachel Thavayogan,Dennis P. Orgill,Duilio Pagano,Prathamesh S. Pai,Somprakas Basu,James McCaul,Frederick H. Millham,Baskaran Vasudevan,Cláudio Rodrigues Leles,Richard David Rosin,Roberto Klappenbach,David Machado-Aranda,Benjamin Perakath,Andrew J. Beamish,Mangesh A. Thorat,M. Hammad Ather,Naheed Farooq,Daniel M. Laskin,Kandiah Raveendran,Joerg Albrecht,James Milburn,Diana Miguel,Indraneil Mukherjee,Michele Valmasoni,James Chi Yong Ngu,Boris Kirshtein,Nicholas Raison,Michael Jennings Boscoe,Maximilian J. Johnston,Jerome R. Hoffman,Mohammad Bashashati,Achilleas Thoma,Donagh Healy,Salvatore Giordano,Oliver J. Muensterer,Huseyin Kadioglu,Abdulrahman Alsawadi,Patrick J. Bradley,Iain J. Nixon,Samuele Massarut,Benjamin Challacombe,Ashraf Noureldin,Mushtaq Chalkoo,Raafat Yahia Afifi,Jeffrey K Aronson,Thomas E. Pidgeon +48 more
TL;DR: The development of the STROCSS guideline (Strengthening the Reporting of Cohort Studies in Surgery), consisting of a 17-item checklist, is described and it is hoped its use will increase the transparency and reporting quality of such studies.
808
Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial
Jayant S. Vaidya,David Joseph,Jeffrey S Tobias,Max Bulsara,Frederik Wenz,Christobel Saunders,Christobel Saunders,Michael Alvarado,Henrik Flyger,Samuele Massarut,Wolfgang Eiermann,Mohammed Keshtgar,John Dewar,Uta Kraus-Tiefenbacher,Marc Sütterlin,Laura J. Esserman,H Holtveg,Mario Roncadin,Steffi Pigorsch,M Metaxas,Mary Falzon,A Matthews,Tammy Corica,Norman R. Williams,Michael Baum +24 more
TL;DR: For selected patients with early breast cancer, a single dose of radiotherapy delivered at the time of surgery by use of targeted intraoperative radiotherapy should be considered as an alternative to external beam radiotherapydelivered over several weeks.
781
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.
Viviana Galimberti,Bernard F. Cole,Giuseppe Viale,Giuseppe Viale,Paolo Veronesi,Paolo Veronesi,Elisa Vicini,Mattia Intra,Giovanni Mazzarol,Samuele Massarut,Janez Zgajnar,Mario Taffurelli,David Littlejohn,Michael Knauer,Carlo Tondini,Angelo Di Leo,Marco Colleoni,Meredith M. Regan,Alan S. Coates,Richard D. Gelber,Aron Goldhirsch,Frances M. Boyle,Guy Jerusalem,Rolf A. Stahel,Stefan Aebi,Michael D. Green,Per Karlsson,Ingrid Kössler,István Láng,Anita Hiltbrunner,Jürg Bernhard,Stamatina Fournarakou,Roswitha Kammler,Rudolf Maibach,Manuela Rabaglio,Karin Ribi,Heidi Roschitzki,Susanne Roux,Barbara Ruepp,Caitlin Mahoney,Karen N. Price,Lynette Blacher,Tara Scolese,Karolyn Scott,Sandra Lippert,Theresa Zielinski,Mauro G. Mastropasqua,Stefania Andrighetto,Patrizia Dell'Orto,Giuseppe Renne,Giancarlo Pruneri,Silvia Dellapasqua,Monica Iorfida,Giuseppe Cancello,Emilia Montagna,Anna Cardillo,Giulia Peruzzotti,R. Ghisini,Alberto Luini,Umberto Veronesi,Oreste Gentilini,Stefano Zurrida,Giuseppe Curigliano,Franco Nolè,Roberto Orecchia,Marisa Cristina Leonardi,Paola Baratella,Camelia Chifu,Manuela Sargenti,Diana Crivellari,Sandro Morassut,Mario Mileto,Erica Piccoli,Andreas Veronesi,Marisa Donatella Magri,Angelo Buonadonna,Ezio Candiani,Antonino Carbone,Tiziana Perin,Rachele Volpe,Mario Roncadin,Mauro Arcicasa,Francesco Coran,Manuela Lagrassa,Angelo Recalcati,Maria Emanuela Limonta,Paolo Tricomi,Privato Fenaroli,Elisabetta Candiago,Laura Cattaneo,Alberto Gianatti,Donatella Santini,Sylvie Maweja,Philippe Delvenne,Andrée Rorive,Joëlle Collignon,Jean-Remi Garbay,Marie-Christine Mathieu,Hanne Galatius,Jack Hoffmann,Peer Schousen,Charlotte Lanng,John Hoerby,Birgitte Bruun Rasmussen,Helle Holtveg,Maj-Lis Moeller Talman,Julio Abugattas,Jose Manuel Cotrina,Richard Dyer,Jurij Lindtner,Elga Majdic,Snjezana Frkovic-Grazio,Christian Oehlschlegel,Gerhard Ries,Michael Töpfer,Ute Lorenz,Otto Schiltknecht,Bruno Späti,Andreas Ehrsam,Monika Bamert,Martina Egli-Tupaj,Christoph Rageth,Elisabeth Saurenmann,Christoph Tausch,Rosmarie Caduff,Holger Moch,Zsuzsanna Varga,Dimitri Sarlos,Elena Kralidis,Rainer Grobholz,Olivia Pagani,Lucia Bronz,Michele Ghielmini,Luca Mazzucchelli,Tiziana Rusca,Thomas Gyr,Linda Leidi,Giorgio Caccia,Daniel Wyss,Martin F. Fey,Michael Müller,Andreas Günthert,Gilles Berclaz,Achim Fleischmann,Jean Francois Delaloye,Assia Treboux,Hans-Anton Lehr,Maryse Fiche,L Perey,Lucien Zaman,Wendy Jeanneret Sozzi,John F. Forbes,D. F. Lindsay,D.F. Preece,Jane Hill,P. Jeal,P. Smart,John J. Collins,Gregory Bruce Mann,Robert Millar,Craig Murphy,Malcolm Buchanan,Anand Murugasu,James French,Elisabeth Elder,Lynette Mann,David Moon,A. Michael Bilous,Nirmala Pathmanathan,Virginia Howard,Petere G. Gill,James Kollias,Melissa Bochner,Linda Madigan,Elisabeth Rippy,Robert Whitfield,Fereshte Farshidi,Katrina Moore,Mark Sywak,L. Tan,William Ross,Karen Briscoe,Allison Jones,Aashit Shah,Elgene Lim,Robert Macindoe,Andrew J. Spillane,S. Fiona Bonar,Hugh Carmalt,Richard West,Cindy Mak,Paul McKenzie,Richard Harman,Susanne Gerred,Eva Juhasz,Stephen Allpress,Julie Craik,Ian G. Campbell,Paul Chin,Lori Hayes,Frederick Mayall,M. Thorburn +201 more
TL;DR: The findings of the IBCSG 23-01 trial corroborate those obtained at 5 years and are consistent with those of the 10-year follow-up analysis of the Z0011 trial, and support the current practice of not doing an axillary dissection when the tumour burden in the sentinel nodes is minimal or moderate.
456